SS
Sunila Sharad Vaknalli
About Sunila Sharad Vaknalli
Data last updated:
Sunila Sharad Vaknalli has 17 years in corporate governance. Holds Director and Designated Partner roles. Currently with 6 companies, including Medisynth Chemicals Pvt Ltd and Beck And Koll Laboratories Private Limited. Formerly with 3 companies, such as New Era Homoeopathic Pharmacy Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹39.26 Cr; the largest is Medisynth Chemicals Pvt Ltd at ₹38.47 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medisynth Chemicals Pvt Ltd U24110MH1983PTC029252 | Director | 30 Aug 2018 | 1983 | ₹38.47 Cr (FY 2025) | Active |
| Medisynth Naturals Private Limited U24239MH1986PTC040532 | Director | 30 Aug 2018 | 1986 | ₹79.1 Lakh (FY 2025) | Active |
 Beck And Koll Laboratories Llp ACS-9632 | Designated Partner | 26 Nov 2025 | 2025 | – | Active |
| Vcnally Sales Llp ACS-5347 | Designated Partner | 07 Nov 2025 | 2025 | – | Active |
| New Era Homoeopathic Pharmacy Llp AAG-3768 | Designated Partner | 16 May 2016 | 2016 | – | Active |
| Vac Pharmaceuticals Pvt. Ltd U24230MH1986PTC040497 | Director | 20 Feb 2009 | 1986 | – | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| New Era Homoeopathic Pharmacy Private Limited U24239MH1974PTC017466 | Director | 20 Feb 2009 | 1974 | – | Converted To Llp |
| Beck And Koll Laboratories Private Limited U24230MH1974PTC017878 | Director | 20 Feb 2009 | 1974 | ₹65,961 (FY 2024) | Converted To Llp |
| Vcnally Sales Private Limited U51100MH1975PTC018730 | Director | 20 Feb 2009 | 1975 | ₹1.5 Lakh (FY 2024) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunila Sharad Vaknalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunila Sharad Vaknalli
Sunila Sharad Vaknalli has 17 years in corporate governance. Holds Director and Designated Partner roles. Currently with 6 companies, including Medisynth Chemicals Pvt Ltd and Beck And Koll Laboratories Private Limited. Formerly with 3 companies, such as New Era Homoeopathic Pharmacy Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹39.26 Cr; the largest is Medisynth Chemicals Pvt Ltd at ₹38.47 Cr (FY 2025).
Sunila Sharad Vaknalli is associated with 6 companies as Director and Designated Partner, including Medisynth Chemicals Pvt Ltd (₹38.47 Cr), Medisynth Naturals Private Limited (₹79.1 Lakh), Beck And Koll Laboratories Llp.
Sunila Sharad Vaknalli has expertise in General Business.
Sunila Sharad Vaknalli has 17 years in corporate governance.
By reported revenue, the largest current company of Sunila Sharad Vaknalli is Medisynth Chemicals Pvt Ltd, with revenue of ₹38.47 Cr (FY 2025).
The 2 current companies of Sunila Sharad Vaknalli that report revenue have a combined latest revenue of ₹39.26 Cr.
Sunila Sharad Vaknalli currently holds positions at 6 companies; the 5 largest by reported revenue are Medisynth Chemicals Pvt Ltd (₹38.47 Cr), Medisynth Naturals Private Limited (₹79.1 Lakh), Beck And Koll Laboratories Llp, Vcnally Sales Llp, New Era Homoeopathic Pharmacy Llp.